Published in J Clin Invest on May 01, 1998
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med (2006) 2.63
Early effect of tidal volume on lung injury biomarkers in surgical patients with healthy lungs. Anesthesiology (2014) 2.06
The inflammasome mediates hyperoxia-induced alveolar cell permeability. J Immunol (2010) 1.67
IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest (2000) 1.66
Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest (2005) 1.61
Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest (2004) 1.51
NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol (2013) 1.46
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J Clin Invest (2004) 1.35
IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am J Respir Cell Mol Biol (2009) 1.33
The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. Am J Respir Crit Care Med (2010) 1.31
Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am J Pathol (2003) 1.31
DNA damage induced by hyperoxia: quantitation and correlation with lung injury. Am J Respir Cell Mol Biol (2006) 1.28
Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. Am J Respir Cell Mol Biol (2011) 1.19
Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am J Pathol (2003) 1.18
IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. Am J Physiol Lung Cell Mol Physiol (2009) 1.17
Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. Free Radic Biol Med (2007) 1.16
Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol (2003) 1.10
IL-6 cytoprotection in hyperoxic acute lung injury occurs via suppressor of cytokine signaling-1-induced apoptosis signal-regulating kinase-1 degradation. Am J Respir Cell Mol Biol (2008) 1.08
Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol (2012) 1.00
Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia. Free Radic Biol Med (2007) 0.96
Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Respir Cell Mol Biol (2008) 0.91
Gene expression profile of human airway epithelium induced by hyperoxia in vivo. Am J Respir Cell Mol Biol (2006) 0.91
Definition of ALI/ARDS. Crit Care Clin (2011) 0.91
Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am J Pathol (2002) 0.90
Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. Am J Respir Cell Mol Biol (2015) 0.90
Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice. Eur J Appl Physiol (2013) 0.90
Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury. Am J Respir Cell Mol Biol (2013) 0.89
Leukemia inhibitory factor signaling is required for lung protection during pneumonia. J Immunol (2012) 0.88
Reciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time. Physiol Genomics (2009) 0.86
Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression. Am J Physiol Lung Cell Mol Physiol (2016) 0.84
A paradoxical protective role for the proinflammatory peptide substance P receptor (NK1R) in acute hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol (2009) 0.84
Gene expression of rat alveolar type II cells during hyperoxia exposure and early recovery. Free Radic Biol Med (2007) 0.84
Adenovirus-mediated transfer of the SOCS-1 gene to mouse lung confers protection against hyperoxic acute lung injury. Free Radic Biol Med (2015) 0.83
IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury. Am J Respir Cell Mol Biol (2014) 0.82
Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia. Respir Res (2011) 0.81
Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia. Infect Immun (2003) 0.80
The role of glycoprotein 130 family of cytokines in fetal rat lung development. PLoS One (2013) 0.79
Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury. Purinergic Signal (2015) 0.79
Dual oxidase 2 in lung epithelia is essential for hyperoxia-induced acute lung injury in mice. Antioxid Redox Signal (2014) 0.79
Hyperoxia accelerates Fas-mediated signaling and apoptosis in the lungs of Legionella pneumophila pneumonia. BMC Res Notes (2011) 0.78
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection. BMC Immunol (2014) 0.78
Multiple and highly divergent IL-11 genes in teleost fish. Immunogenetics (2005) 0.76
Histologic evaluation of normobaric oxygen therapy safety in an animal model. Jundishapur J Nat Pharm Prod (2012) 0.76
Resistin deficiency in mice has no effect on pulmonary responses induced by acute ozone exposure. Am J Physiol Lung Cell Mol Physiol (2015) 0.76
Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem (1971) 28.59
Catalase in vitro. Methods Enzymol (1984) 27.79
Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 13.90
Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem (1980) 10.52
Assays of glutathione peroxidase. Methods Enzymol (1984) 6.76
Biology of disease: free radicals and tissue injury. Lab Invest (1982) 6.09
Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol (1990) 6.05
Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis (1980) 3.08
Lipid peroxidation damage to cell components. Fed Proc (1973) 2.93
Oxidative stress: from basic research to clinical application. Am J Med (1991) 2.82
The biochemistry of programmed cell death. FASEB J (1995) 2.63
bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A (1993) 2.39
Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol (1986) 2.25
Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A (1990) 2.03
Pulmonary strategies of antioxidant defense. Am Rev Respir Dis (1989) 1.94
Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest (1997) 1.74
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A (1994) 1.65
Oxygen poisoning in mice. Ultrastructural and surfactant studies during exposure and recovery. Arch Pathol (1970) 1.63
Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol (1996) 1.60
Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol (1997) 1.58
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest (1996) 1.58
Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis (1981) 1.33
Cellular oxygen toxicity. Oxidant injury without apoptosis. J Biol Chem (1996) 1.26
Interleukin-11 inhibits macrophage interleukin-12 production. J Immunol (1997) 1.18
Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood (1994) 1.14
Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. J Lab Clin Med (1985) 1.14
Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem Pharmacol (1987) 1.12
A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood (1994) 1.07
Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a. Am J Respir Cell Mol Biol (1996) 1.05
Increase in microvascular permeability induced by enzymatically generated free radicals. I. In vivo study. Microvasc Res (1981) 1.05
Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol (1996) 1.00
Pulmonary injury in rats following continuous exposure to 60% O2 for 7 days. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.98
IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol (1996) 0.97
Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphologic features of apoptosis. Proc Natl Acad Sci U S A (1995) 0.96
Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol (1996) 0.94
Pulmonary O2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res (1995) 0.92
Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells. Biochem Biophys Res Commun (1992) 0.92
Interleukin 1 protects rats against oxygen toxicity. J Appl Physiol (1985) (1991) 0.91
Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol (1997) 0.91
Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci (1996) 0.91
Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells. Biochem Biophys Res Commun (1992) 0.89
IL-6 enhances TNF-alpha- and IL-1-induced increase of Mn superoxide dismutase mRNA and O2 tolerance. Am J Physiol (1992) 0.89
Comparison of pulmonary neutrophils in the adult and neonatal rat after hyperoxia. Pediatr Res (1995) 0.87
Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol (1995) 0.86
Mechanism of endothelial cell shape change in oxidant injury. J Surg Res (1989) 0.86
Oxygen-induced lung injury in the guinea pig proceeds through CD18-independent mechanisms. Am J Respir Crit Care Med (1994) 0.84
Purification and characterization of selenium-glutathione peroxidase from hamster liver. Arch Biochem Biophys (1983) 0.83
Cellular distribution of pulmonary Mn and CuZn superoxide dismutase: effect of hyperoxia and interleukin-1. J Histochem Cytochem (1994) 0.83
Oxygen radicals and lung injury. Acta Anaesthesiol Scand Suppl (1991) 0.81
Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators. Acta Anaesthesiol Scand (1995) 0.81
An age-related difference in hyperoxia lethality: role of lung antioxidant defense mechanisms. Am J Physiol (1995) 0.81
Glutathione peroxidase and glutathione reductase activities towards glutathione-derived antioxidants. Biochem Biophys Res Commun (1994) 0.80
Apoptosis and its regulation. Adv Exp Med Biol (1996) 0.79
Interleukin-1alpha induced protection against pulmonary oxygen toxicity. Am J Physiol (1994) 0.78
Artificial surfactant attenuates hyperoxic lung injury in primates. II. Morphometric analysis. J Appl Physiol (1985) (1995) 0.77
Endotoxin induces glutathione reductase activity in lungs of mice. Pediatr Res (1994) 0.77
Pulmonary oxygen toxicity. Bronchoalveolar lavage demonstration of early parameters of alveolitis. Chest (1983) 0.77
Pulmonary oxygen toxicity. Clin Chest Med (1982) 0.77
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res (2001) 4.16
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med (1997) 3.33
Airway remodeling in asthma. J Clin Invest (1999) 3.19
One-year outcome of elderly and young patients admitted to intensive care units. Crit Care Med (1993) 2.58
Optimal positioning for cervical immobilization. Ann Emerg Med (1996) 2.55
Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med (1985) 2.42
A half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child (1981) 2.36
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Quality of life measures before and one year after admission to an intensive care unit. Crit Care Med (1995) 2.35
The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med (1994) 2.23
Development of a toxicological gene array and quantitative assessment of this technology. Arch Biochem Biophys (2000) 2.13
Insulin-treated diabetes and driving in the UK. Diabet Med (2002) 2.07
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess (2013) 2.06
Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med (2000) 2.05
Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol (2000) 2.03
Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest (1994) 1.96
A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn. N Engl J Med (1976) 1.96
T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med (1999) 1.85
Air insufflation technique of enteral tube insertion: a randomized, controlled trial. Crit Care Med (1998) 1.77
Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med (1988) 1.77
Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest (1997) 1.74
Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73
Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol (1999) 1.70
IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest (2000) 1.66
Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest (1996) 1.66
Cost accounting of adult intensive care: methods and human and capital inputs. Crit Care Med (1996) 1.65
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest (1996) 1.58
Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol (2000) 1.51
Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem (2001) 1.48
Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest (1998) 1.47
S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem (1994) 1.46
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am Rev Respir Dis (1985) 1.45
Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2001) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem (1994) 1.40
High-throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates. Proc Natl Acad Sci U S A (1998) 1.37
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol (1985) 1.32
The mechanism of oxidative phosphorylation. XIV. Purification and properties of a second energy-transfer factor. Arch Biochem Biophys (1967) 1.31
Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest (1996) 1.27
Functional EGF receptors are present on mouse embryo tissues. Nature (1981) 1.25
Importance of radiant flux in the treatment of hyperbilirubinemia: failure of overhead phototherapy units in intensive care units. Pediatrics (1976) 1.21
Carbon monoxide attenuates aeroallergen-induced inflammation in mice. Am J Physiol Lung Cell Mol Physiol (2001) 1.20
The regulation of lung fibroblast proliferation by alveolar macrophages in experimental silicosis. Am Rev Respir Dis (1984) 1.19
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacol Bull (1993) 1.19
Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology (2000) 1.19
Interleukin-11 inhibits macrophage interleukin-12 production. J Immunol (1997) 1.18
Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am J Respir Cell Mol Biol (2000) 1.17
Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. N Engl J Med (1978) 1.14
Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. Proc Natl Acad Sci U S A (1985) 1.14
Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13
Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest (2001) 1.13
Hypersensitivity reactions to ethylenediamine in aminophylline. Am Rev Respir Dis (1981) 1.12
Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest (1992) 1.11
Improved method of nasojejunal feeding in low-birth-weight infants. J Pediatr (1974) 1.11
Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol (1997) 1.11
Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care. Eye (Lond) (2012) 1.11
Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol (1996) 1.10
Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering. Oncogene (2010) 1.09
Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am Rev Respir Dis (1987) 1.07
Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol (2000) 1.05
Spondylodiscitis (disc space infection) associated with negative microbiological tests: comparison of outcome of suspected disc space infections to documented non-tuberculous pyogenic discitis. Br J Neurosurg (2007) 1.05
Regulation of mitochondrial respiration in senescence. J Cell Physiol (1972) 1.04
A quantitative assessment of gamma-motoneuron contribution to the achilles tendon reflex in normal subjects. Arch Phys Med Rehabil (1968) 1.04
IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J Immunol (2000) 1.03
Traumatic total iridectomy due to iris extrusion through a self-sealing cataract incision. Arch Ophthalmol (1999) 1.03
A survey of patients leaving a mental hospital against medical advice. Hosp Community Psychiatry (1976) 1.02
Cardiac hypertrophy in rats with iron and copper deficiency: quantitative contribution of mitochondrial enlargement. Pediatr Res (1970) 1.02
The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am J Psychiatry (1979) 1.01
Studies on oxidative phosphorylation. XV. Latent adenosine 5'-triphosphatase activity of factor A. Arch Biochem Biophys (1968) 1.00
Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med (2001) 0.98
Chlorine spot treatment of flooded tube wells, an efficacy trial. J Appl Microbiol (2006) 0.98
Spontaneous production of interleukin-1 by human alveolar macrophages. Clin Immunol Immunopathol (1983) 0.98
Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics (1975) 0.98
IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol (2000) 0.97
IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol (1996) 0.97
Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis (1987) 0.96
Effect of vitamin E on the development of oxygen-induced lung injury in neonates. Ann N Y Acad Sci (1982) 0.96
The entire nucleotide sequence of foxtail mosaic virus RNA. J Gen Virol (1991) 0.96
Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease. Eur Respir J (1997) 0.96
Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J Biol Chem (1998) 0.96
Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost (1999) 0.96
Neonates of less than or equal to 1,250 grams birth weight: prospective neurodevelopmental evaluation during the first year post-term. Pediatrics (1982) 0.96